Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity-Reference-Cited by-同舟云学术

Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

Published:1983-10 Issue:2 Volume:116 Page:492-499
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Choay J.,Petitou M.,Lormeau J.C.,Sinaÿ P.,Casu B.,Gatti G.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference24 articles.

1. The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor

2. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin

3. The molecular-weight-dependence of the anti-coagulant activity of heparin

4. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma

5. On the molecular-weight-dependence of the anticoagulant activity of heparin

Cited by 663 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect;Nature Communications;2024-08-08

2. Relation between antithrombin-III activity and activated clotting time for cardiopulmonary bypass;Journal of Artificial Organs;2024-08-02

3. Inhibition of catechol-O-methyltransferase (COMT) by heparin oligosaccharides with specific structures;Carbohydrate Polymers;2024-05

4. Differential Solvent DEEP-STD NMR and MD Simulations Enable the Determinants of the Molecular Recognition of Heparin Oligosaccharides by Antithrombin to Be Disentangled;International Journal of Molecular Sciences;2024-04-25

5. Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes;Annales de Biologie Clinique;2024-04